Clinical Guidelines for Thyroid Nodules in Special Populations

Abstract

Thyroid nodules are increasingly detected due to the widespread use of high-resolution imaging. While most nodules are benign, certain populations—including pregnant women, pediatric patients, elderly individuals, and those with a history of radiation exposure—present unique diagnostic and therapeutic challenges. This review synthesizes current evidence and recent clinical guidelines to provide a comprehensive, mechanism-based, and clinically relevant approach to the management of thyroid nodules in these special populations. Emphasis is placed on epidemiology, pathophysiology, risk stratification, diagnostic modalities, management options, and emerging advances, with a focus on balancing diagnostic accuracy, procedural risks, and individualized patient care.

Introduction

Thyroid nodules are common in clinical practice, with prevalence rates that vary according to age, gender, and risk profile. Special populations, such as children, pregnant women, the elderly, and individuals with prior head and neck irradiation, require tailored approaches due to altered risks of malignancy, diagnostic limitations, and varied therapeutic thresholds. Recent guidelines from leading endocrine societies emphasize risk-adapted strategies and highlight the importance of individualized management. This article provides a detailed review of the epidemiology, pathophysiology, clinical presentation, and current best practices in the evaluation and treatment of thyroid nodules in these special populations.

Epidemiology / Disease Burden

The prevalence of thyroid nodules in the general population ranges from 19% to 68% on ultrasonography, with higher rates in women and older adults. In children, nodules are less common but carry a higher malignancy risk—up to 25% compared to 5–15% in adults. Pregnant women often develop or experience growth of nodules due to physiological hormonal changes, while those with prior radiation exposure are at increased risk for both benign and malignant nodular disease. The growing public health burden is magnified by greater detection rates and the need for nuanced management in vulnerable groups.

Pathophysiology

Thyroid nodule development is driven by a complex interplay of genetic, environmental, and hormonal factors. In children, germline mutations and post-radiation DNA damage are predominant etiologies. During pregnancy, elevated estrogen and human chorionic gonadotropin levels stimulate thyroid cell proliferation, predisposing to nodule formation. In the elderly, accumulated somatic mutations and chronic iodine deficiency play a bigger role. Understanding these mechanisms aids in risk stratification and tailoring surveillance and treatment.

Risk Factors

Risk factors for thyroid nodules and malignancy include female sex, increasing age, family history of thyroid cancer or genetic syndromes (e.g., MEN2, Cowden syndrome), exposure to ionizing radiation, and pre-existing thyroid disease. Special populations present distinct profiles: children and those with radiation exposure have a higher malignant potential; pregnancy is associated with rapid nodule growth but not necessarily increased malignancy risk. Elderly patients often have co-morbidities that complicate workup and management decisions.

Clinical Features

Thyroid nodules are usually asymptomatic and discovered incidentally. Compressive symptoms (dysphagia, hoarseness, neck discomfort) are less common but may occur with large or rapidly growing nodules, especially in elderly or pregnant patients. In children, palpable neck masses often prompt evaluation, while in the elderly, symptoms may be subtle or attributed to other causes. Red flag signs—including rapid growth, fixation, vocal cord paralysis, and cervical lymphadenopathy—warrant urgent assessment for malignancy.

Diagnosis

Evaluation begins with a thorough clinical history and physical examination, focusing on risk factors and worrisome features. Ultrasound remains the gold standard for nodule characterization, providing information on size, echogenicity, margins, calcifications, and vascularity. In children and pregnant women, radiation-free imaging is preferred; fine-needle aspiration (FNA) is the diagnostic procedure of choice, guided by ultrasound and risk assessment. Serum TSH measurement is essential; additional molecular testing is considered in indeterminate cytology, especially for pediatric or high-risk nodules. In pregnancy, FNA is deferred if possible until after delivery unless suspicion for malignancy is high.

Treatment & Management

Management is guided by malignancy risk, patient age, comorbidity, and patient preferences. Most benign nodules require observation with periodic ultrasound. Surgery is indicated for confirmed or highly suspicious malignancy, symptomatic nodules, or those with concerning growth. In children, a more aggressive surgical approach is warranted due to higher malignancy risk. Pregnant women with indeterminate or suspicious nodules may undergo surgery in the second trimester if indicated, but most can be monitored until postpartum. Elderly patients benefit from individualized management, balancing surgical risks with the potential benefits. Radioactive iodine is avoided in pregnancy and used judiciously in young children. Minimally invasive approaches, including thermal ablation, are emerging options in select patients.

Recent Advances / Emerging Therapies

Molecular diagnostics, such as gene expression classifiers and next-generation sequencing panels, have improved risk stratification and reduced unnecessary surgeries, especially in indeterminate nodules. Novel minimally invasive techniques, including radiofrequency and laser ablation, provide alternatives to surgery for benign or recurrent nodules, with encouraging safety and efficacy profiles in select groups. For pediatric and pregnant patients, ongoing research is refining diagnostic thresholds and therapeutic timing to optimize outcomes while minimizing harm.

Guideline Recommendations

The American Thyroid Association (ATA), European Thyroid Association (ETA), and other societies advocate risk-adapted, evidence-based management. In children, prompt evaluation and lower thresholds for FNA are recommended. For pregnant women, deferment of surgery until postpartum is preferred unless high-risk malignancy is suspected. Elderly patients should be assessed for surgical fitness, with non-surgical management for low-risk lesions. Shared decision-making, multidisciplinary input, and patient-centered care underpin all recommendations, ensuring that the unique risks and needs of special populations are addressed.

Conclusion

Thyroid nodule management in special populations demands a nuanced, evidence-guided approach that incorporates population-specific risks, diagnostic nuances, and individualized therapeutic strategies. Advances in molecular diagnostics and minimally invasive therapies are transforming care paradigms. Adherence to clinical guidelines and ongoing research are critical to optimizing outcomes and reducing unnecessary interventions, particularly in children, pregnant women, elderly individuals, and those with unique risk profiles.